NORCROSS, Ga., May 25 /PRNewswire-FirstCall/ -- Immucor, Inc. , a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced it expects to release its fiscal 2008 guidance on Thursday, May 31 2007, after the close of regular trading hours, and then host a conference call on Friday, June 1, 2007 at 8:30 AM (EDT) to discuss expectations for fiscal 2008. Investors are invited to participate in this conference call with, Dr. Gioacchino De Chirico, President and Chief Executive Officer, Patrick D. Waddy, Chief Financial Officer, and Edward L. Gallup, consultant. The release will be posted on Immucor's website, as well as any financial information that may be discussed by Dr. De Chirico, Mr. Waddy or Mr. Gallup during this call not contained in the release. Both the release and the additional financial information, if any, will be posted as soon as practicable after the call on the investor news section of Immucor's website. To access this information once posted, go to Immucor's website at www.immucor.com and click on "About Us - Press Releases."
To participate in the telephone conference call, dial 1-888-324-2874 and passcode BLUD. Replays of the conference call will be available for one week beginning at 12:00 noon on June 1, 2007 by calling 1-800-294-0342. Beginning June 8, 2007, audio of the conference call or a transcript of the audio will be available on the "About Us - Press Releases" page of the Immucor website.
For more information on Immucor, please visit our website at www.immucor.com.
Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of our market segments.
Immucor, Inc.CONTACT: Patrick Waddy of Immucor, Inc., +1-770-441-2051
Web site: http://www.immucor.com//
